Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 1/20 | 0.38 |
| ▸ | CA3 | P07451 | 1/20 | 0.37 |
| ▸ | CA6 | P23280 | 1/20 | 0.37 |
| ▸ | CA5A | P35218 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.37 |
| ▸ | PSEN1 | P49768 | 2/20 | 0.37 |
| ▸ | PSEN2 | P49810 | 2/20 | 0.37 |
| ▸ | APH1B | Q8WW43 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3738485 | 0.86 | KCNH2 (0.43) | KDM4ESMN1; SMN2TSHRHTTUSP2 | |
| SCHEMBL13290762 | 0.84 | KMT2A (0.45) | KDM4ESMN1; SMN2TSHRHTTUSP2 | |
| SCHEMBL15353070 | 0.82 | KDM4E (0.41) | PKMKDM4ESMN1; SMN2TSHRHTT | |
| SCHEMBL15353058 | 0.82 | KDM4E (0.42) | KDM4ESMN1; SMN2TSHRHTTUSP2 | |
| SCHEMBL15352925 | 0.82 | TRPV4 (0.46) | KDM4ETSHRNPC1RAB9A | |
| SCHEMBL16467750 | 0.82 | PKM (0.44) | PKMKDM4ESMN1; SMN2TSHRHTT | |
| SCHEMBL8412332 | 0.81 | PKM (0.41) | PKMKDM4ESMN1; SMN2TSHRHTT | |
| SCHEMBL8854691 | 0.81 | PKM (0.38) | PKMKDM4ESMN1; SMN2TSHRHTT | |
| SCHEMBL15352355 | 0.80 | APLNR (0.42) | SMN1; SMN2TSHRHTTKAT6A | |
| SCHEMBL15352923 | 0.79 | KMT2A (0.45) | PKMKDM4ESMN1; SMN2TSHRHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110635167-B | Nonaqueous electrolyte solution, battery containing same, and electric vehicle | 比亚迪股份有限公司 | 2021-04-20 | — | — | CN | claimed |
| CN-110635167-A | Nonaqueous electrolyte solution, battery containing same, and electric vehicle | 比亚迪股份有限公司 | 2019-12-31 | — | — | CN | claimed |
| CN-110635167-B | Nonaqueous electrolyte solution, battery containing same, and electric vehicle | 比亚迪股份有限公司 | 2021-04-20 | — | — | CN | disclosed |
| EP-2841429-B1 | TETRAZOLINONE COMPOUNDS AND ITS USE AS PESTICIDES | SUMITOMO CHEMICAL CO (JP) | 2020-10-21 | — | — | EP | disclosed |
| CN-110635167-A | Nonaqueous electrolyte solution, battery containing same, and electric vehicle | 比亚迪股份有限公司 | 2019-12-31 | — | — | CN | disclosed |
| US-9565856-B2 | Tetrazolinone compounds and its use as pesticides | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-02-14 | — | — | US | disclosed |
| US-20150051171-A1 | TETRAZOLINONE COMPOUNDS AND ITS USE AS PESTICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150051171-A1 | TETRAZOLINONE COMPOUNDS AND ITS USE AS PESTICIDES | CBR3, CYCS, CBR1 | PKM 1646/4885KDM4E 3020/4885SMN1; SMN2 3453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.